Correlation Between Amgen and Repligen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Repligen, you can compare the effects of market volatilities on Amgen and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Repligen.

Diversification Opportunities for Amgen and Repligen

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Amgen and Repligen is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Amgen i.e., Amgen and Repligen go up and down completely randomly.

Pair Corralation between Amgen and Repligen

Given the investment horizon of 90 days Amgen Inc is expected to under-perform the Repligen. But the stock apears to be less risky and, when comparing its historical volatility, Amgen Inc is 1.83 times less risky than Repligen. The stock trades about -0.21 of its potential returns per unit of risk. The Repligen is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  13,487  in Repligen on August 30, 2024 and sell it today you would earn a total of  1,512  from holding Repligen or generate 11.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  Repligen

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Repligen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Repligen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Repligen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Amgen and Repligen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and Repligen

The main advantage of trading using opposite Amgen and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.
The idea behind Amgen Inc and Repligen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data